Back
Spok Holdings Vs. Novo Nordisk AS Industry Stock Comparison
Buy
54
SPOK
Spok Holdings
Last Price:
$15.95
Seasonality Move:
0.13%
Sell
13
NONOF
Novo Nordisk AS
Last Price:
$84.75
Seasonality Move:
6.94%
Buy
54
Spok Holdings (SPOK)
is a Buy
Is Spok Holdings a Buy, Sell or Hold?
-
The current Spok Holdings [SPOK] share price is $15.96. The Score for SPOK is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
SPOK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
13
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $84.75. The Score for NONOF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
SPOK Stock Price Chart
What is Spok Holdings's stock price today?
-
The Spok Holdings share price today is $15.96Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPOK is experiencing selling pressure, which indicates risk of future bearish movement.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $84.75Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.
SPOK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.08 | Buy |
Relative Strength Index (14 RSI): | 41.8 | Sell |
Chaikin Money Flow: | -172955 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.18 - 16.66) | Sell |
Bollinger Bands (100): | (14.67 - 16.25) | Buy |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.51 | Sell |
Relative Strength Index (14 RSI): | 24.55 | Sell |
Chaikin Money Flow: | 64911 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (100.57 - 111.43) | Sell |
Bollinger Bands (100): | (107.18 - 131.16) | Sell |
SPOK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.53 | Sell |
20-day SMA: | 16.48 | Sell |
50-day SMA: | 16.01 | Sell |
200-day SMA: | 15.46 | Buy |
8-day EMA: | 16.41 | Sell |
20-day EMA: | 16.42 | Sell |
50-day EMA: | 16.1 | Sell |
200-day EMA: | 15.45 | Buy |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 105.03 | Sell |
20-day SMA: | 106.85 | Sell |
50-day SMA: | 109.33 | Sell |
200-day SMA: | 126.14 | Sell |
8-day EMA: | 102.09 | Sell |
20-day EMA: | 105.65 | Sell |
50-day EMA: | 110.06 | Sell |
200-day EMA: | 118.01 | Sell |
Spok Holdings Earnings Growth & SPOK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.06 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.
Spok Holdings Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |